MARK S RUBIN
Allopathic & Osteopathic Physicians|Internal Medicine|Medical Oncology BONITA SPRINGS, FL NPI 1033192570
Browse related groups: Allopathic & Osteopathic Physicians|Internal Medicine|Medical Oncology FL Janssen Biotech, Inc. All categories
General Payments — all program years on this page
$9,114.51
- Category: General Payments
- Program years: PY2018–2024
- Record count: 263
- As of (CMS publication): 2026-01-23
Latest program year (PY2024): $783.35 across 36 records · disputed records: 0
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How this figure is calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
Latest program year (PY2024) · sorted by reported total.
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $783.35 | 36 |
By paying entity
Latest program year (PY2024) · sorted by reported total.
| Paying entity | Amount | Records |
|---|---|---|
| Janssen Biotech, Inc. | $140.43 | 7 |
| ABBVIE INC. | $87.07 | 3 |
| Daiichi Sankyo Inc. | $87.04 | 4 |
| Incyte Corporation | $80.72 | 4 |
| SpringWorks Therapeutics, Inc. | $56.07 | 2 |
| Astellas Pharma US Inc | $42.85 | 2 |
| Rigel Pharmaceuticals, Inc. | $34.87 | 1 |
| ARRAY BIOPHARMA INC | $28.74 | 1 |
| PFIZER INC. | $25.78 | 1 |
| BeiGene USA, Inc. | $23.25 | 1 |
| Acrotech Biopharma Inc. | $23.17 | 1 |
| Merck Sharp & Dohme Corporation | $20.72 | 1 |
| GENZYME CORPORATION | $19.25 | 1 |
| EISAI INC. | $18.71 | 1 |
| Bayer HealthCare Pharmaceuticals Inc. | $17.01 | 1 |
| Alnylam Pharmaceuticals Inc. | $16.73 | 1 |
| NOVARTIS PHARMACEUTICALS CORPORATION | $16.31 | 1 |
| Tempus AI, Inc | $15.24 | 1 |
| Veracyte, Inc. | $14.97 | 1 |
| Pharmacosmos Therapeutics Inc. | $14.42 | 1 |
By program year
Records — PY2024 (36)
Provenance & corrections
- Dataset: CMS Open Payments — General Payments
- Source: CMS Open Payments dataset (bulk file)
- Publisher of source data: Centers for Medicare & Medicaid Services
- Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.